These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20555262)

  • 21. Increased mortality and perioperative complications in patients with previous elective percutaneous coronary interventions undergoing coronary artery bypass surgery.
    Bonaros N; Hennerbichler D; Friedrich G; Kocher A; Pachinger O; Laufer G; Bonatti J
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):846-52. PubMed ID: 19327507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in the management of coronary artery disease: highlights from the literature.
    Augoustides JG; Ramakrishna H
    J Cardiothorac Vasc Anesth; 2009 Apr; 23(2):259-65. PubMed ID: 19324285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal revascularization strategies for multivessel coronary artery disease.
    Daemen J; Serruys PW
    Curr Opin Cardiol; 2006 Nov; 21(6):595-601. PubMed ID: 17053410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is noninvasive risk stratification sufficient, or should all patients undergo cardiac catheterization and angiography after a myocardial infarction?
    Kulick DL; Rahimtoola SH
    Cardiovasc Clin; 1990; 21(1):3-25; discussion 26-9. PubMed ID: 2199055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health-related quality of life outcomes of patients with coronary artery disease treated with cardiac surgery, percutaneous coronary intervention or medical management.
    Norris CM; Saunders LD; Ghali WA; Brant R; Galbraith PD; Graham M; Faris P; Dzavik V; Knudtson ML;
    Can J Cardiol; 2004 Oct; 20(12):1259-66. PubMed ID: 15494780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternative therapeutic strategies for patients with severe end-stage coronary artery disease not amenable to conventional revascularization.
    Almeda FQ; Parrillo JE; Klein LW
    Catheter Cardiovasc Interv; 2003 Sep; 60(1):57-66. PubMed ID: 12929105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Almanac 2011: stable coronary artery disease. An editorial overview of selected research that has driven recent advances in clinical cardiology.
    Henderson RA; Timmis AD
    Heart; 2011 Oct; 97(19):1552-9. PubMed ID: 21900584
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical implications of the BARI 2D and COURAGE trials of coronary artery disease.
    Kuller LH
    Coron Artery Dis; 2010 Nov; 21(7):391-6. PubMed ID: 20634693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of completeness of revascularization on the five-year outcome in percutaneous coronary intervention and coronary artery bypass graft patients (from the ARTS-II study).
    Sarno G; Garg S; Onuma Y; Gutiérrez-Chico JL; van den Brand MJ; Rensing BJ; Morel MA; Serruys PW;
    Am J Cardiol; 2010 Nov; 106(10):1369-75. PubMed ID: 21059423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications.
    Brar SS; Syros G; Dangas G
    Angiology; 2008; 59(2 Suppl):83S-8S. PubMed ID: 18544582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic evaluation of alternative strategies to treat patients with diabetes mellitus and coronary artery disease.
    Hlatky MA; Melsop KA; Boothroyd DB;
    Am J Cardiol; 2006 Jun; 97(12A):59G-65G. PubMed ID: 16813739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.
    Mercado N; Wijns W; Serruys PW; Sigwart U; Flather MD; Stables RH; O'Neill WW; Rodriguez A; Lemos PA; Hueb WA; Gersh BJ; Booth J; Boersma E
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):512-9. PubMed ID: 16077421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment decisions in stable coronary artery disease: insights from the Euro Heart Survey on Coronary Revascularization.
    Breeman A; Hordijk-Trion M; Lenzen M; Hoeks S; Ottervanger JP; Bertrand ME; Sechtem U; Zaliunas R; Legrand V; de Boer MJ; Stahle E; Mercado N; Wijns W; Boersma E;
    J Thorac Cardiovasc Surg; 2006 Nov; 132(5):1001-9. PubMed ID: 17059915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of atrial fibrillation on outcome in patients with known or suspected coronary artery disease referred for exercise stress testing.
    Bouzas-Mosquera A; Peteiro J; Broullón FJ; Alvarez-García N; Mosquera VX; Casas S; Pérez A; Méndez E; Castro-Beiras A
    Am J Cardiol; 2010 May; 105(9):1207-11. PubMed ID: 20403467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of interventional treatment of stress positive coronary artery disease.
    Adamu U; Knollmann D; Alrawashdeh W; Almutairi B; Deserno V; Kleinhans E; Schäfer W; Hoffmann R
    Am J Cardiol; 2010 Jun; 105(11):1535-9. PubMed ID: 20494657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients.
    Stroupe KT; Morrison DA; Hlatky MA; Barnett PG; Cao L; Lyttle C; Hynes DM; Henderson WG;
    Circulation; 2006 Sep; 114(12):1251-7. PubMed ID: 16966588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Narrowing the gap: early and intermediate outcomes after percutaneous coronary intervention and coronary artery bypass graft procedures in California, 1997 to 2006.
    Carey JS; Danielsen B; Milliken J; Li Z; Stabile BE
    J Thorac Cardiovasc Surg; 2009 Nov; 138(5):1100-7. PubMed ID: 19837215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of multivessel coronary artery disease.
    Parikh PB; Kirtane AJ; Moses JW
    Panminerva Med; 2013 Dec; 55(4):311-26. PubMed ID: 24434340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical implications of the BARI 2D and COURAGE trials: overview.
    Brooks MM; Boden WE; Frye RL
    Coron Artery Dis; 2010 Nov; 21(7):383-5. PubMed ID: 20664331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of coronary artery disease in end-stage renal disease.
    Roberts JK; Patel UD
    Semin Dial; 2011; 24(5):525-32. PubMed ID: 21906164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.